Postnatal administration of dexamethasone for weaning off the ventilator affects thyroid function

Neonatology

Volumn 94, Issue 3, 2008, Pages 164-169

  Buimer, Maarten ^a   Van Wassenaer, Aleid G ^a   Kok, Joke H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Dexamethasone, adverse effects; Infant, newborn; Infant, premature; Psychomotor disorders; Thyroid hormones

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ARTICLE; ARTIFICIAL VENTILATION; BEHAVIOR DISORDER; CEREBRAL PALSY; CLINICAL ARTICLE; DRUG FATALITY; HUMAN; LIOTHYRONINE BLOOD LEVEL; NEWBORN; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; STATISTICS, NONPARAMETRIC; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VENTILATOR WEANING;

EID: 53549129976     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000143395     Document Type: Article

References (36)

1. Halliday HL, Ehrenkranz RA, Doyle LW: Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;1:CD001144.
2. Yeh TF, Lin YJ, Huang CC, Chen JY, Lin CH, Lin HC, et al: Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998;101:e7.
3. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG III, et al: Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999;104:15-21.
4. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, et al: Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal 2000;83:F177-F181.
5. Romagnoli C, Zecca E, Luciano R, Torrioli G, Tortorolo G: A three year follow-up of preterm infants after moderately early treatment with dexamethasone. Arch Dis Child Fetal Neonatal 2002;87:F55-F58.
6. Stoelhorst GM, Rijken M, Martens SE, van Zwieten PH, Feenstra J, Zwinderman AH, et al: Developmental outcome at 18 and 24 months of age in very preterm children: a cohort study from 1996 to 1997. Early Hum Dev 2003;72:83-95.
7. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, et al: Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-1313.
8. Weichsel ME Jr: The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards. Ann Neurol 1977;2:364-366.
9. Gramsbergen A, Mulder EJ: The influence of betamethasone and dexamethasone on motor development in young rats. Pediatr Res 1998;44:105-110.
10. Kauffman KS, Seidler FJ, Slotkin TA: Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. Pediatr Res 1994;35:515-522.
11. Bernal J, Guadano-Ferraz A, Morte B: Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 2003;13:1005-1012.
12. van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ: Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 1997;42:604-609.
13. Lucas A, Morley R, Fewtrell MS: Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow-up. BMJ 1996;312:1132-1143.
14. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M: The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821-827.
15. Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH: Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712-728.
16. La Gamma EF, van Wassenaer AG, Golombek SG, Morreale de EG, Kok JH, Quero J, et al: Neonatal thyroxine supplementation for transient hypothyroxinemia of prematurity: beneficial or detrimental? Treat Endocrinol 2006;5:335-346.
17. 3). J Clin Endocrinol Metab 1975;41:911-920.
18. Ahlquist JA, Franklyn JA, Ramsden DB, Sheppard MC: The influence of dexamethasone on serum thyrotrophin and thyrotrophin synthesis in the rat. Mol Cell Endocrinol 1989;64:55-61.
19. Courtin F, Chantoux F, Gavaret JM, Toru-Delbauffe D, Jacquemin C, Pierre M: Induction of type II 5′-deiodinase activity in cultured rat astroglial cells by 12-O-tetradecanoylphorbol-13-acetate: dependence on glucocorticoids. Endocrinology 1989;125:1277-1281.
20. Darras VM, Kotanen SP, Geris KL, Berghman LR, Kuhn ER: Plasma thyroid hormone levels and iodothyronine deiodinase activity following an acute glucocorticoid challenge in embryonic compared with posthatch chickens. Gen Comp Endocrinol 1996;104:203-212.
21. Van der Geyten S, Buys N, Sanders JP, Decuypere E, Visser TJ, Kuhn ER, et al: Acute pretranslational regulation of type III iodothyronine deiodinase by growth hormone and dexamethasone in chicken embryos. Mol Cell Endocrinol 1999;147:49-56.
22. Van der Geyten S., Darras VM: Developmentally defined regulation of thyroid hormone metabolism by glucocorticoids in the rat. J Endocrinol 2005;185:327-336.
23. Forhead AJ, Jellyman JK, Gardner DS, Giussani DA, Kaptein E, Visser TJ, et al: Differential effects of maternal dexamethasone treatment on circulating thyroid hormone concentrations and tissue deiodinase activity in the pregnant ewe and fetus. Endocrinology 2007;148:800-805.
24. Martin CR, Van Marter LJ, Allred EN, Leviton A: Antenatal glucocorticoids increase early total thyroxine levels in premature infants. Biol Neonate 2005;87:273-280.
25. Williams FL, Ogston SA, van Toor H, Visser TJ, Hume R: Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 2005;90:5954-5963.
26. Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB: Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics 2007;119:716-721.
27. 3); thesis, Academic Medical Center, Amsterdam, 1979.
28. Williams FL, Simpson J, Delahunty C, Ogston SA, Bongers-Schokking JJ, Murphy N, et al: Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004;89:5314-5320.
29. Petersen MC, Nation RL, McBride WG, Ashley JJ, Moore RG: Pharmacokinetics of betamethasone in healthy adults after intravenous administration. Eur J Clin Pharmacol 1983;25:643-650.
30. McIver B, Gorman CA: Euthyroid sick syndrome: an overview. Thyroid 1997;7:125-132.
31. Samuels MH, Luther M, Henry P, Ridgway EC: Effects of hydrocortisone on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab 1994;78:211-215.
32. Coiro V, Volpi R, Capretti L, Speroni G, Pilla S, Cataldo S, et al: Effect of dexamethasone on TSH secretion induced by TRH in human obesity. J Invest Med 2001;49:330-334.
33. Richard K, Hume R, Kaptein E, Sanders J, van Toor H, de Herder W, et al: Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab 1998;83:2868-2874.
34. Pavelka S, Kopecky P, Bendlova B, Stolba P, Vitkova I, Vobruba V, et al: Tissue metabolism and plasma levels of thyroid hormones in critically ill very premature infants. Pediatr Res 1997;42:812-818.
35. Hernandez A: Structure and function of the type 3 deiodinase gene. Thyroid 2005;15:865-874.
36. Pallud S, Ramauge M, Gavaret JM, Lennon AM, Munsch N, St Germain DL, et al: Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the Erk cascade. Endocrinology 1999;140:2917-2923.